Awareness of recently implemented—or ongoing—advances by the pharmacopoeias can help biotherapeutic manufacturers remain compliant with current requirements. The increased number and complexity of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback